Report cover image

Global Spermicides Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 192 Pages
SKU # APRC20359878

Description

Summary

According to APO Research, the global Spermicides market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Spermicides is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Spermicides is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Spermicides market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Spermicides is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Spermicides market include Advantage-S, Conceptrol, Crinone, Delfen Foam, Emko, Encare, Endometrin, First-Progesterone VGS and Gynol II, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Spermicides, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Spermicides, also provides the sales of main regions and countries. Of the upcoming market potential for Spermicides, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Spermicides sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Spermicides market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Spermicides sales, projected growth trends, production technology, application and end-user industry.

Spermicides Segment by Company

Advantage-S
Conceptrol
Crinone
Delfen Foam
Emko
Encare
Endometrin
First-Progesterone VGS
Gynol II
Phexxi
Prochieve
Spermicides Segment by Type

Suppositories
Creams
Foams
Gels
Film
Spermicides Segment by Application

Online Pharmacies
Retail Pharmacies
Hospital
Spermicides Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Spermicides status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Spermicides market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Spermicides significant trends, drivers, influence factors in global and regions.
6. To analyze Spermicides competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spermicides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Spermicides and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spermicides.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Spermicides market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Spermicides industry.
Chapter 3: Detailed analysis of Spermicides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Spermicides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Spermicides in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Table of Contents

192 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Spermicides Sales Value (2020-2031)
1.2.2 Global Spermicides Sales Volume (2020-2031)
1.2.3 Global Spermicides Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Spermicides Market Dynamics
2.1 Spermicides Industry Trends
2.2 Spermicides Industry Drivers
2.3 Spermicides Industry Opportunities and Challenges
2.4 Spermicides Industry Restraints
3 Spermicides Market by Company
3.1 Global Spermicides Company Revenue Ranking in 2024
3.2 Global Spermicides Revenue by Company (2020-2025)
3.3 Global Spermicides Sales Volume by Company (2020-2025)
3.4 Global Spermicides Average Price by Company (2020-2025)
3.5 Global Spermicides Company Ranking (2023-2025)
3.6 Global Spermicides Company Manufacturing Base and Headquarters
3.7 Global Spermicides Company Product Type and Application
3.8 Global Spermicides Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Spermicides Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Spermicides Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Spermicides Market by Type
4.1 Spermicides Type Introduction
4.1.1 Suppositories
4.1.2 Creams
4.1.3 Foams
4.1.4 Gels
4.1.5 Film
4.2 Global Spermicides Sales Volume by Type
4.2.1 Global Spermicides Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Spermicides Sales Volume by Type (2020-2031)
4.2.3 Global Spermicides Sales Volume Share by Type (2020-2031)
4.3 Global Spermicides Sales Value by Type
4.3.1 Global Spermicides Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Spermicides Sales Value by Type (2020-2031)
4.3.3 Global Spermicides Sales Value Share by Type (2020-2031)
5 Spermicides Market by Application
5.1 Spermicides Application Introduction
5.1.1 Online Pharmacies
5.1.2 Retail Pharmacies
5.1.3 Hospital
5.2 Global Spermicides Sales Volume by Application
5.2.1 Global Spermicides Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Spermicides Sales Volume by Application (2020-2031)
5.2.3 Global Spermicides Sales Volume Share by Application (2020-2031)
5.3 Global Spermicides Sales Value by Application
5.3.1 Global Spermicides Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Spermicides Sales Value by Application (2020-2031)
5.3.3 Global Spermicides Sales Value Share by Application (2020-2031)
6 Spermicides Regional Sales and Value Analysis
6.1 Global Spermicides Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Spermicides Sales by Region (2020-2031)
6.2.1 Global Spermicides Sales by Region: 2020-2025
6.2.2 Global Spermicides Sales by Region (2026-2031)
6.3 Global Spermicides Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Spermicides Sales Value by Region (2020-2031)
6.4.1 Global Spermicides Sales Value by Region: 2020-2025
6.4.2 Global Spermicides Sales Value by Region (2026-2031)
6.5 Global Spermicides Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Spermicides Sales Value (2020-2031)
6.6.2 North America Spermicides Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Spermicides Sales Value (2020-2031)
6.7.2 Europe Spermicides Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Spermicides Sales Value (2020-2031)
6.8.2 Asia-Pacific Spermicides Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Spermicides Sales Value (2020-2031)
6.9.2 South America Spermicides Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Spermicides Sales Value (2020-2031)
6.10.2 Middle East & Africa Spermicides Sales Value Share by Country, 2024 VS 2031
7 Spermicides Country-level Sales and Value Analysis
7.1 Global Spermicides Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Spermicides Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Spermicides Sales by Country (2020-2031)
7.3.1 Global Spermicides Sales by Country (2020-2025)
7.3.2 Global Spermicides Sales by Country (2026-2031)
7.4 Global Spermicides Sales Value by Country (2020-2031)
7.4.1 Global Spermicides Sales Value by Country (2020-2025)
7.4.2 Global Spermicides Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Spermicides Sales Value Growth Rate (2020-2031)
7.5.2 USA Spermicides Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Spermicides Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Spermicides Sales Value Growth Rate (2020-2031)
7.6.2 Canada Spermicides Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Spermicides Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Spermicides Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Spermicides Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Spermicides Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Spermicides Sales Value Growth Rate (2020-2031)
7.8.2 Germany Spermicides Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Spermicides Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Spermicides Sales Value Growth Rate (2020-2031)
7.9.2 France Spermicides Sales Value Share by Type, 2024 VS 2031
7.9.3 France Spermicides Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Spermicides Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Spermicides Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Spermicides Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Spermicides Sales Value Growth Rate (2020-2031)
7.11.2 Italy Spermicides Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Spermicides Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Spermicides Sales Value Growth Rate (2020-2031)
7.12.2 Spain Spermicides Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Spermicides Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Spermicides Sales Value Growth Rate (2020-2031)
7.13.2 Russia Spermicides Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Spermicides Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Spermicides Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Spermicides Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Spermicides Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Spermicides Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Spermicides Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Spermicides Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Spermicides Sales Value Growth Rate (2020-2031)
7.16.2 China Spermicides Sales Value Share by Type, 2024 VS 2031
7.16.3 China Spermicides Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Spermicides Sales Value Growth Rate (2020-2031)
7.17.2 Japan Spermicides Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Spermicides Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Spermicides Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Spermicides Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Spermicides Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Spermicides Sales Value Growth Rate (2020-2031)
7.19.2 India Spermicides Sales Value Share by Type, 2024 VS 2031
7.19.3 India Spermicides Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Spermicides Sales Value Growth Rate (2020-2031)
7.20.2 Australia Spermicides Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Spermicides Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Spermicides Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Spermicides Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Spermicides Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Spermicides Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Spermicides Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Spermicides Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Spermicides Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Spermicides Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Spermicides Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Spermicides Sales Value Growth Rate (2020-2031)
7.24.2 Chile Spermicides Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Spermicides Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Spermicides Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Spermicides Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Spermicides Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Spermicides Sales Value Growth Rate (2020-2031)
7.26.2 Peru Spermicides Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Spermicides Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Spermicides Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Spermicides Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Spermicides Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Spermicides Sales Value Growth Rate (2020-2031)
7.28.2 Israel Spermicides Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Spermicides Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Spermicides Sales Value Growth Rate (2020-2031)
7.29.2 UAE Spermicides Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Spermicides Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Spermicides Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Spermicides Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Spermicides Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Spermicides Sales Value Growth Rate (2020-2031)
7.31.2 Iran Spermicides Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Spermicides Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Spermicides Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Spermicides Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Spermicides Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Advantage-S
8.1.1 Advantage-S Comapny Information
8.1.2 Advantage-S Business Overview
8.1.3 Advantage-S Spermicides Sales, Value and Gross Margin (2020-2025)
8.1.4 Advantage-S Spermicides Product Portfolio
8.1.5 Advantage-S Recent Developments
8.2 Conceptrol
8.2.1 Conceptrol Comapny Information
8.2.2 Conceptrol Business Overview
8.2.3 Conceptrol Spermicides Sales, Value and Gross Margin (2020-2025)
8.2.4 Conceptrol Spermicides Product Portfolio
8.2.5 Conceptrol Recent Developments
8.3 Crinone
8.3.1 Crinone Comapny Information
8.3.2 Crinone Business Overview
8.3.3 Crinone Spermicides Sales, Value and Gross Margin (2020-2025)
8.3.4 Crinone Spermicides Product Portfolio
8.3.5 Crinone Recent Developments
8.4 Delfen Foam
8.4.1 Delfen Foam Comapny Information
8.4.2 Delfen Foam Business Overview
8.4.3 Delfen Foam Spermicides Sales, Value and Gross Margin (2020-2025)
8.4.4 Delfen Foam Spermicides Product Portfolio
8.4.5 Delfen Foam Recent Developments
8.5 Emko
8.5.1 Emko Comapny Information
8.5.2 Emko Business Overview
8.5.3 Emko Spermicides Sales, Value and Gross Margin (2020-2025)
8.5.4 Emko Spermicides Product Portfolio
8.5.5 Emko Recent Developments
8.6 Encare
8.6.1 Encare Comapny Information
8.6.2 Encare Business Overview
8.6.3 Encare Spermicides Sales, Value and Gross Margin (2020-2025)
8.6.4 Encare Spermicides Product Portfolio
8.6.5 Encare Recent Developments
8.7 Endometrin
8.7.1 Endometrin Comapny Information
8.7.2 Endometrin Business Overview
8.7.3 Endometrin Spermicides Sales, Value and Gross Margin (2020-2025)
8.7.4 Endometrin Spermicides Product Portfolio
8.7.5 Endometrin Recent Developments
8.8 First-Progesterone VGS
8.8.1 First-Progesterone VGS Comapny Information
8.8.2 First-Progesterone VGS Business Overview
8.8.3 First-Progesterone VGS Spermicides Sales, Value and Gross Margin (2020-2025)
8.8.4 First-Progesterone VGS Spermicides Product Portfolio
8.8.5 First-Progesterone VGS Recent Developments
8.9 Gynol II
8.9.1 Gynol II Comapny Information
8.9.2 Gynol II Business Overview
8.9.3 Gynol II Spermicides Sales, Value and Gross Margin (2020-2025)
8.9.4 Gynol II Spermicides Product Portfolio
8.9.5 Gynol II Recent Developments
8.10 Phexxi
8.10.1 Phexxi Comapny Information
8.10.2 Phexxi Business Overview
8.10.3 Phexxi Spermicides Sales, Value and Gross Margin (2020-2025)
8.10.4 Phexxi Spermicides Product Portfolio
8.10.5 Phexxi Recent Developments
8.11 Prochieve
8.11.1 Prochieve Comapny Information
8.11.2 Prochieve Business Overview
8.11.3 Prochieve Spermicides Sales, Value and Gross Margin (2020-2025)
8.11.4 Prochieve Spermicides Product Portfolio
8.11.5 Prochieve Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Spermicides Value Chain Analysis
9.1.1 Spermicides Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Spermicides Sales Mode & Process
9.2 Spermicides Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Spermicides Distributors
9.2.3 Spermicides Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.